Machine Learning with F-Sodium Fluoride PET and Quantitative Plaque Analysis on CT Angiography for the Future Risk of Myocardial Infarction.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
PMID:

Abstract

Coronary F-sodium fluoride (F-NaF) PET and CT angiography-based quantitative plaque analysis have shown promise in refining risk stratification in patients with coronary artery disease. We combined both of these novel imaging approaches to develop an optimal machine-learning model for the future risk of myocardial infarction in patients with stable coronary disease. Patients with known coronary artery disease underwent coronary F-NaF PET and CT angiography on a hybrid PET/CT scanner. Machine-learning by extreme gradient boosting was trained using clinical data, CT quantitative plaque analysis, measures and F-NaF PET, and it was tested using repeated 10-fold hold-out testing. Among 293 study participants (65 ± 9 y; 84% male), 22 subjects experienced a myocardial infarction over the 53 (40-59) months of follow-up. On univariable receiver-operator-curve analysis, only F-NaF coronary uptake emerged as a predictor of myocardial infarction (c-statistic 0.76, 95% CI 0.68-0.83). When incorporated into machine-learning models, clinical characteristics showed limited predictive performance (c-statistic 0.64, 95% CI 0.53-0.76) and were outperformed by a quantitative plaque analysis-based machine-learning model (c-statistic 0.72, 95% CI 0.60-0.84). After inclusion of all available data (clinical, quantitative plaque and F-NaF PET), we achieved a substantial improvement ( = 0.008 versus F-NaF PET alone) in the model performance (c-statistic 0.85, 95% CI 0.79-0.91). Both F-NaF uptake and quantitative plaque analysis measures are additive and strong predictors of outcome in patients with established coronary artery disease. Optimal risk stratification can be achieved by combining clinical data with these approaches in a machine-learning model.

Authors

  • Jacek Kwiecinski
    Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Evangelos Tzolos
    Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Mohammed N Meah
    BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Sebastien Cadet
  • Philip D Adamson
    Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
  • Kajetan Grodecki
    Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Nikhil V Joshi
    Bristol Heart Institute, University of Bristol, United Kingdom; and.
  • Alastair J Moss
    BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Michelle C Williams
    British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Cres, Edinburgh, UK.
  • Edwin J R van Beek
    Department of Radiology, University of Edinburgh, and Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland, UK.
  • Daniel S Berman
    Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • David E Newby
    Edinburgh Imaging Facility QMRI, Edinburgh, EH16 4TJ, UK; Centre for Cardiovascular Science, Edinburgh, EH16 4TJ, UK.
  • Damini Dey
    Departments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Taper A238, Los Angeles, CA, 90048, USA.
  • Marc R Dweck
    British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Cres, Edinburgh, UK.
  • Piotr J Slomka
    Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California Piotr.Slomka@cshs.org.